| Predicate |
Object |
| contentType |
Journal Article |
| issn |
1662-5099 |
| pageRange |
33- |
| publicationName |
Frontiers in Molecular Neuroscience |
| startingPage |
33 |
| bibliographicCitation |
Emamian ES. AKT/GSK3 signaling pathway and schizophrenia. Front Mol Neurosci. 2012;5():33. PMID: 22435049; PMCID: PMC3304298. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dae0a34761afde169a0aaf0dddadc5d5 |
| date |
2012 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3304298
https://pubmed.ncbi.nlm.nih.gov/22435049
https://doi.org/10.3389/fnmol.2012.00033 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34620
https://portal.issn.org/resource/ISSN/1662-5099 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
AKT/GSK3 signaling pathway and schizophrenia |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8369f7c690795caa54317214d5efb891
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9168
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4c4bdf82d37a2ce63b2f824bcede49bf
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559 |